This is a composite tapering journal built from documented Indian psychiatric practice patterns. The patient is a 34-year-old IT professional in Bengaluru, on clonazepam 1 mg daily (0.5 mg morning + 0.5 mg night) for 18 months following a panic disorder diagnosis. The taper plan was structured by a senior psychiatrist at Cadabams, with concurrent escitalopram cross-titration and weekly CBT.
The 90-day arc — from 1 mg daily down to zero — follows a 12.5% reduction every 2 weeks. The journal records sleep data from a Fitbit Charge 6, daily anxiety scores on the GAD-7 self-report scale, symptom logs, and the actual conversations with the psychiatrist that shaped each dose change.
For the clinical context on benzodiazepine dependence in India, the broader anxiety treatment landscape, and the systemic reasons clonazepam over-prescription is common in Indian psychiatry, read the Anxiety Disorders in India pillar guide. This journal focuses on the lived experience and tactical detail of what 90 days of tapering actually looks like.
Pre-Taper Baseline — Day 0
Patient context
- 34-year-old male, Bengaluru, IT senior engineer
- Panic disorder diagnosed 18 months ago after recurrent ER visits — see the panic vs heart attack patient pathways for the ER pathway he came through
- On clonazepam 0.5 mg twice daily for 18 months
- Escitalopram 10 mg started 4 months ago after switching psychiatrists
- No prior history of substance use
- Married, no children, regular gym-goer pre-panic disorder
Baseline measurements
| Metric | Day 0 Value |
|---|---|
| GAD-7 score | 4/21 (mild) |
| Sleep duration (mean, 14 days) | 7h 12min |
| Sleep onset latency | 22 minutes |
| Night awakenings | 1.4 per night |
| Resting heart rate | 68 bpm |
| HRV (RMSSD) | 42 ms |
| Panic attacks last 30 days | 0 |
| Caffeine intake | 2 cups coffee + 1 chai daily |
| Alcohol intake | 2 drinks per week |
The plan
Reduce clonazepam by 0.125 mg every 14 days. Continue escitalopram at 10 mg. Begin weekly CBT focused on panic-disorder skills (Barlow Unified Protocol). Add CBT-I (cognitive behavioral therapy for insomnia) when sleep becomes a problem. Cut caffeine to one morning cup. Stop alcohol entirely for the duration of the taper. Schedule psychiatrist check-ins every 2 weeks.
Week 1 — Dose 1.0 mg → 0.875 mg
Day 1–3
First dose reduction. Cut the evening 0.5 mg to 0.375 mg (one and a half quarter-tablets). Day 1 was uneventful. Day 2, mild irritability in the late afternoon. Day 3, woke at 4 AM, could not fall back asleep — first sleep disruption.
Day 4–7
Sleep onset latency increased from 22 to 38 minutes. Two night awakenings instead of one. GAD-7 climbed to 7. Resting heart rate up to 74. Mild hand tremor in the morning after caffeine. Walked 5 km on Day 6 and felt the symptoms settle for several hours afterward.
Week 1 sleep data
| Day | Duration | Onset Latency | Awakenings | Deep Sleep |
|---|---|---|---|---|
| 1 | 7h 04m | 25m | 1 | 1h 32m |
| 2 | 6h 58m | 28m | 1 | 1h 28m |
| 3 | 6h 12m | 35m | 2 | 1h 18m |
| 4 | 6h 25m | 40m | 2 | 1h 14m |
| 5 | 6h 40m | 32m | 2 | 1h 22m |
| 6 | 6h 55m | 28m | 1 | 1h 30m |
| 7 | 6h 48m | 30m | 1 | 1h 28m |
Psychiatrist message — end of Week 1
“This is exactly what we expected. The first wave of symptoms is your GABA receptors recalibrating. Hold steady. Do not increase the dose. Keep the SSRI at 10 mg. Add 30 minutes of aerobic walking daily. Cut the chai if you can.”
CBT Session 1
Focus — psychoeducation about benzodiazepine withdrawal physiology. The therapist explained that the rebound anxiety is neurochemical adaptation, not a return of the original disorder. This single distinction reduced catastrophizing significantly.
Week 2 — Dose remains 0.875 mg, stabilization
Day 8–14
Symptoms peaked around Day 9–10, then began easing. Sleep improved back toward 7 hours. GAD-7 dropped to 5. The morning tremor diminished. Began doing slow Surya Namaskar — 5 rounds at 6 breath cycles each — every morning before breakfast. Pulse settled at 70 bpm by week’s end.
Week 2 reflections
The first reduction was harder than expected but manageable. The wave-like pattern is real. Trust the protocol. Do not chase symptoms with dose increases.
Week 3 — Dose 0.875 mg → 0.75 mg
Day 15–17
Second reduction. Cut the morning 0.5 mg to 0.375 mg. Symptoms began appearing on Day 16 — slightly worse than the first reduction. Mild derealization at the desk during a long Zoom call. 90-second slow breathing exercise resolved it.
Day 18–21
Sleep dropped to 6 hours. Two awakenings. Increased early morning anxiety. GAD-7 climbed to 9. Hands trembling noticeably during morning coffee.
CBT Session 2
Began the panic-disorder Barlow protocol — interoceptive exposure. The therapist had me deliberately hyperventilate for 60 seconds and notice the sensations. The point — to teach the brain that the sensations of panic are not dangerous in themselves. Then a worry hierarchy was constructed.
Psychiatrist call — Day 20
Brief phone consultation. Discussed adding hydroxyzine 25 mg as-needed for breakthrough anxiety. Did not need it that week but knowing it was available reduced the anticipatory anxiety.
Week 4 — Stabilization at 0.75 mg
Day 22–28
Symptoms eased after Day 25. Sleep recovered to 6h 30m. GAD-7 dropped to 6. Resting heart rate back to 72. The pattern of week-1-rough, week-2-easier was confirming. The wave model held.
Behavioral additions this week
- Cut second coffee. Now down to one morning cup.
- Added 20 minutes of evening walk after dinner.
- Started reading a non-medical novel before bed instead of phone scrolling.
- Sleep onset latency dropped back to 25 minutes.
Week 5 — Dose 0.75 mg → 0.625 mg
Day 29–32
Third reduction. Cut from 0.375 mg morning + 0.375 mg evening to 0.375 mg morning + 0.25 mg evening. Day 31 was the hardest day so far — woke at 3:40 AM with heart racing, took 45 minutes to calm down. Used 4-7-8 breathing and a cold-water face wash. GAD-7 spiked to 11.
Day 33–35
Continued sleep disruption. Tried 25 mg hydroxyzine on Day 34 for the first time at bedtime. Helped sleep — sedation was clear. Did not feel hungover the next morning. Useful tool but worried about dependency from a different angle. Discussed with psychiatrist.
Psychiatrist note — Day 35
“Hydroxyzine is fine for 5–7 nights during a rough phase. It is not a benzodiazepine, no GABA action, no dependency risk in the same way. Use it strategically. Stop when the phase eases. Continue the protocol.”
Week 6 — Stabilization at 0.625 mg, CBT-I starts
Day 36–42
Sleep continued to be the weakest variable. The CBT-I module began with the clinical psychologist. Core elements —
- Sleep restriction — bed only when sleepy, leave bed if awake for 20+ minutes
- Stimulus control — bed only for sleep and sex, not phone or reading
- Fixed wake time — 6:30 AM regardless of how the night went
- No daytime naps beyond 20 minutes before 3 PM
- Sleep diary — track every night
After 3 weeks of CBT-I, sleep efficiency improved from 78% to 88%. Sleep duration stabilized around 6h 30m and felt more restorative.
Week 7 — Dose 0.625 mg → 0.5 mg
Day 43–49
Halfway point — both literally (half the original dose) and emotionally. Symptoms intensity was the highest at days 44–46, then began easing. GAD-7 hit 12 at peak, dropped to 8 by end of week. The realization that I was halfway through, and that the pattern was holding, gave morale a boost.
Week 7 anxiety log entries
- Day 43, 11 AM — wave of derealization at office. Used grounding (5-4-3-2-1 sensory check). Resolved in 8 minutes.
- Day 44, 6 PM — chest tightness reading email. Walked outside for 10 minutes. Resolved.
- Day 45, 3 AM — anxious awakening. 4-7-8 breathing for 5 minutes. Back to sleep in 25 minutes.
- Day 46, 9 AM — tremor with morning coffee. Skipped coffee for the day. Tremor settled by noon.
- Day 47, throughout day — mild background anxiety, GAD-7 8.
- Day 48 — better, GAD-7 6, normal sleep.
- Day 49 — best day of the week, GAD-7 5, did 5 km walk and weights session, slept 7h 10m.
Week 8 — Stabilization at 0.5 mg
Day 50–56
Symptoms eased. Sleep recovered. The CBT-I work was paying off — even rough nights felt less catastrophic because the morning routine held steady. Began thinking about post-taper life realistically. What would the SSRI dose look like? Would I need ongoing CBT? Did I need to plan for relapse prevention?
Psychiatrist consultation — Week 8
Discussed —
- Continue current protocol — every 14 days, reduce 0.125 mg
- SSRI plan — escitalopram 10 mg to continue for at least 6 months post-taper
- CBT plan — complete 16-session course, then monthly maintenance for 6 months
- Relapse prevention plan — early warning signs, breathing protocol, when to call for help
- Long-term outlook — most patients with treated panic disorder stay in remission with SSRI + maintenance CBT
Week 9 — Dose 0.5 mg → 0.375 mg
Day 57–63
Third quarter reduction. Now down to 0.25 mg morning + 0.125 mg evening. Symptoms appeared on Day 58 — sleep onset took 50 minutes, then 2 awakenings. Used hydroxyzine on Day 59 and 60. Symptoms peaked Day 60–61, then began easing.
Week 9 reflections
The smaller absolute dose changes (0.125 mg out of 0.5 mg = 25% reduction) felt proportionally larger than the early ones. The brain notices the percentage drop more than the absolute milligram drop. Knowing this in advance helped — expecting it took the catastrophizing away.
Week 10 — Stabilization at 0.375 mg
Day 64–70
By mid-week 10, I was beginning to feel structurally different. Less reactive. Calmer baseline. The escitalopram was clearly doing its work without the clonazepam masking it. GAD-7 settled at 5 for 4 consecutive days. Sleep at 6h 45m average. Started light running 3 days a week — couch-to-5K style program, building cardio gradually. See the belly fat exercises guide for the conditioning approach used.
Week 11 — Dose 0.375 mg → 0.25 mg
Day 71–77
Penultimate quarter reduction. Now on 0.125 mg morning + 0.125 mg evening — equal halves, simple to manage. Sleep dropped briefly to 6h 15m on Day 72, recovered by Day 75. GAD-7 spiked to 8 on Day 73, settled to 5 by Day 77.
Anticipating the final stretch
Talked with the psychiatrist about the last two reductions. The plan —
- Week 11–12 — 0.25 mg (already in progress)
- Week 13 — 0.125 mg (single morning dose)
- Week 14 — 0 (off)
Some psychiatrists do alternating-day dosing for the final weeks (0.125 mg every other day) before stopping. The choice depends on the patient’s response — clean even reductions or alternating. We chose clean reductions for predictability.
Week 12 — Stabilization at 0.25 mg, preparing for the off-day
Day 78–84
Stable. Sleep at 7 hours. GAD-7 at 4. Daytime functioning normal. The body had adapted to a low clonazepam level. The escitalopram was at full effect after 5+ months. CBT skills were embedded — I caught my own panic-style thoughts within seconds and reframed them automatically.
Relapse prevention planning — final CBT session before the off-day
The clinical psychologist and I drafted a written relapse prevention plan —
- Early warning signs — disrupted sleep 3+ consecutive nights, increased anticipatory anxiety, avoidance behaviors returning, derealization episodes
- First-line response — return to daily breathing exercises, increase CBT homework, call psychiatrist within 7 days
- Second-line response — increase SSRI dose temporarily, consider brief CBT booster sessions, no return to benzodiazepines without psychiatric agreement
- Crisis response — Tele-MANAS 14416, psychiatrist emergency line, family awareness
- Long-term maintenance — exercise 4 days/week, sleep hygiene, caffeine limited to one morning cup, alcohol limited, CBT booster monthly for 6 months, then quarterly
Week 13 — Dose 0.25 mg → 0.125 mg
Day 85–87
Final lead-up. Cut to 0.125 mg morning only, no evening dose. The evening felt strange initially — the body had had clonazepam in the evening for 18 months. Used a hydroxyzine 25 mg on the first two nights to bridge the change. Sleep was good — 6h 50m and 7h 5m.
Day 88–91
Settled at 0.125 mg. GAD-7 at 4. Sleep stable. The final reduction felt smaller than expected — possibly because the absolute milligrams were now tiny, and the brain had been gradually rebalancing for 12 weeks.
Day 92 — Off Clonazepam
The first day at zero
Took the last 0.125 mg the previous morning. Day 92 — no dose. Heart rate 71. GAD-7 at 4. Sleep duration 7h. Sleep onset 23 minutes. Two awakenings, one for bathroom, one brief. Resolved both back to sleep within minutes.
The next 14 days were what I had expected to be the hardest — and they were not. The waves were smaller. The body had been preparing for zero for the previous month. The escitalopram was at full effect. The CBT skills were second nature.
Post-taper week 1
- GAD-7 — averaged 5
- Sleep — averaged 6h 50m
- Caffeine — one morning cup
- Exercise — running 3 days, Surya Namaskar daily
- Hydroxyzine — used 2 nights for breakthrough sleep
- Psychiatrist contact — one phone check-in on Day 95, brief, all stable
Post-taper week 2
- GAD-7 — averaged 4
- Sleep — averaged 7h
- Hydroxyzine — used 0 nights
- Functioning — normal at work, normal in family life, no avoidance behaviors
What This Taper Cost — in Money and Time
Direct costs over 90 days
| Item | Cost |
|---|---|
| Psychiatrist visits (5 × ₹2,500) | ₹12,500 |
| Telepsychiatry calls (3 × ₹1,500) | ₹4,500 |
| CBT sessions (13 × ₹2,500) | ₹32,500 |
| Escitalopram (continuing) | ₹450 |
| Clonazepam (tapering supply) | ₹120 |
| Hydroxyzine PRN | ₹150 |
| Total | ₹50,220 |
Time investment
- Psychiatrist visits — 5 hours total
- CBT sessions — 13 hours
- Daily CBT homework — 30 min × 90 days = 45 hours
- Breath practice and Surya Namaskar — 20 min × 90 days = 30 hours
- Exercise — 4 hours per week × 13 weeks = 52 hours
- Total — approximately 145 hours over 90 days
The time investment is substantial. The financial cost is meaningful but lower than 6–12 months of failed cold-turkey attempts and ER visits.
Six Indian Psychiatrist Tapering Approaches Compared
Approaches vary across Indian metros. Composite of psychiatrist practice patterns from Bengaluru (NIMHANS-trained, Cadabams, Fortis), Mumbai (Hinduja, KEM, Masina), Delhi (AIIMS, IHBAS, VIMHANS), Hyderabad (Apollo, KIMS), Chennai (SCARF, Apollo), Pune (Sahyadri, Ruby Hall).
| Approach | Strategy | Pace | Typical Length (from 1 mg) |
|---|---|---|---|
| Linear reduction | Reduce 10–15% every 14 days, stay on clonazepam | Steady | 16–20 weeks |
| Modified Ashton | Convert to diazepam first, then taper diazepam | Slow and controlled | 20–32 weeks |
| Front-loaded | Faster early reductions, slow at low doses | Asymmetric | 12–18 weeks |
| Back-loaded | Slow early reductions, faster at low doses | Asymmetric | 16–22 weeks |
| Cross-titration with SSRI dose escalation | SSRI dose goes up as clonazepam goes down | Coordinated | 16–24 weeks |
| Outpatient detox programs (Cadabams etc.) | Structured residential or day-program with team | Intensive | 4–8 weeks residential + outpatient continuation |
The 90-day journal above used a modified linear reduction with concurrent SSRI maintenance and CBT-I integration.
What Helped and What Did Not
Helped
- Concurrent SSRI — escitalopram at therapeutic dose before tapering started — see the escitalopram medicine page
- Weekly CBT — both panic-protocol and CBT-I modules
- Slow Surya Namaskar daily — calmed nervous system, predictable cadence
- Light running — built cardio without triggering interoceptive panic
- Eliminating second coffee and alcohol — both clearly aggravators
- Fixed sleep schedule — bedrock of recovery
- Hydroxyzine PRN — for breakthrough sleep, used 8 nights total
- Family awareness — wife knew the plan, was not catastrophizing each rough day
- Psychiatrist availability — phone access for urgent questions
Did not help
- Reading r/benzowithdrawal on Reddit — full of catastrophic accounts, increased anticipatory anxiety
- Trying zolpidem (Z-drug) for sleep — created its own grogginess, dropped after 2 nights
- Trying ashwagandha at high doses during taper — caused jitteriness, possibly an interaction issue; reduced to 300 mg KSM-66, then to zero during the taper, restarted post-taper (refer the Ashwagandha medicine page)
- Late-night phone scrolling — disrupted sleep
- Skipping CBT homework during rough weeks — made the next week worse
- Comparing to other people’s timelines — every taper is individual
What If Tapering Fails?
Some tapers stall. Some patients need to hold a dose for 4 weeks instead of 2. Some need to step back up by one increment temporarily and then resume. None of this is failure — it is calibration.
Markers that suggest slower pace needed
- Sleep below 5 hours for 5+ consecutive nights
- GAD-7 above 12 for more than 7 days
- Panic attacks returning at frequency above baseline
- Suicidal thinking — immediate medical attention required, call Tele-MANAS 14416
- Inability to function at work or home
- Use of breakthrough benzodiazepines from family supplies or elsewhere
What to do
Call the psychiatrist. Step the dose back up. Hold. Reassess CBT, SSRI dose, sleep, exercise, stressors. Plan a slower taper with smaller increments and longer hold periods. There is no shame in adjusting. The goal is sustainable discontinuation, not speed.
After Zero — Maintenance and Relapse Prevention
The first 90 days off clonazepam are the highest-risk relapse window. Most patients who stay off at month 6 stay off long-term. The maintenance protocol —
- SSRI at therapeutic dose for at least 12 months post-taper, often 24
- CBT booster sessions — monthly for first 6 months, then quarterly
- Sleep discipline — fixed schedule, no late caffeine, screens off
- Exercise — 4 days per week minimum
- Stress management — slow breathwork daily, meditation if it works for you
- No PRN benzodiazepines for breakthrough anxiety — use hydroxyzine or wait it out
- Periodic re-evaluation with psychiatrist every 3–6 months
- Family awareness — they know the relapse warning signs
- Workplace awareness — at minimum, knowing when to take a day off
- Plan for life stressors — births, deaths, job changes, moves — extra CBT support around these
Cluster Cross-Linking
For complete context on the anxiety treatment landscape in India —
- Pillar — Anxiety Disorders in India — GAD, Social Anxiety, Panic Disorder Explained
- Panic Attack vs Heart Attack — 10 Patient Pathways for the ER pathway that often leads to the first clonazepam prescription
- How to Find a Real CBT Therapist in India — required for a successful taper
- Indian Health Insurance Anxiety Coverage for navigating costs
- NIMHANS Bengaluru Walk-In Guide for free or low-cost psychiatric oversight
Cross-cluster — the depression in India pillar, free DMHP government depression treatment guide, and the thyroid problems pillar cover comorbid conditions and rule-outs relevant to any patient on long-term clonazepam.
Sources & References
- Ashton CH — “Benzodiazepines — How They Work and How to Withdraw” (the Ashton Manual), Newcastle University, UK
- Indian Psychiatric Society — Clinical Practice Guidelines for Anxiety Disorders, 2017
- NICE Guidelines — Generalized Anxiety Disorder and Panic Disorder, UK National Institute for Health and Care Excellence
- American Psychiatric Association — Practice Guidelines on Treatment of Patients with Panic Disorder
- Barlow DH — Unified Protocol for Transdiagnostic Treatment of Emotional Disorders, Oxford University Press
- NIMHANS Bengaluru Department of Psychiatry — Inpatient Detoxification Protocols (publicly described in conference proceedings)
- AIIMS New Delhi — Benzodiazepine Tapering Guidelines for Outpatient Settings
- Cochrane Database — Benzodiazepine Discontinuation Strategies
This journal is a composite drawn from documented Indian clinical practice patterns and is for informational and educational purposes. Every clonazepam taper requires individualized psychiatric supervision — do not attempt self-tapering. Withdrawal seizures are a real risk. If you are experiencing severe symptoms during a taper, contact your psychiatrist immediately or visit your nearest emergency department. Tele-MANAS national mental health helpline — 14416. Reviewed by healthcare professionals for India-specific clinical practice as of May 2026.